Digestive System Irritable Bowel Syndrome
| Publication Date | March 2008 |
|---|---|
| Publisher | Life Science Analytics |
| Product Type | Report |
| Pages | 123 |
| ISBN Number | not applicable |
| Product Code | LSA02346 |
Summary
Life Science Analytics', Dermatology Psoriasis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Life Science Analytics' Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Content
- Recent Highlights and Changes
- Upcoming Patent Expires by Therapy Area
- Psoriasis Pipeline Overview
- % of Projects (by Phase of Development)
- No. of Projects by Phase of Development
- Marketed Products vs. Pipeline Products
- Company Overview - Pipeline Projects
- Company Overview - Pipeline Projects
- Top Companies in late stage Psoriasis Projects
- Allergan Inc
- Abbott Laboratories
- Biovitrum AB
- BioCryst Pharmaceuticals Inc
- Celgene Corporation
- Bristol-Myers Squibb Company
- Centocor, Inc.
- CellGate, Inc
- ChemoCentryx, Inc.
- Cephalon Inc
- Cytochroma Inc.
- CollaGenex Pharmaceuticals Inc
- Hybrigenics
- Genmab A/S
- Ligand Pharmaceuticals Inc
- LEO Pharma A/S
- Manhattan Pharmaceuticals Inc.
- Lupin Ltd
- PharmaMar
- Merrimack Pharmaceuticals, Inc.
- Top Companies in early stage Psoriasis Projects
- AnGes MG, Inc.
- Amgen Inc
- Biofrontera AG
- Bayer Schering Pharma AG
- Can-Fite BioPharma, Ltd.
- BTG plc
- Echo Therapeutics, Inc
- Cephalon Inc
- Genmab A/S
- Eli Lilly & Co
- Kemia, Inc
- Genzyme Corporation
- LEO Pharma A/S
- Laboratorios Almirall, S.A.
- MediQuest Therapeutics, Inc.
- Ligand Pharmaceuticals Inc
- Sosei Group Corporation
- Novartis AG
- Tolerx, Inc.
- Stiefel Laboratories, Inc.
- Pipeline Revenue
- Pipeline Revenue
- Full Pipeline View
- Pre Clinical Pipeline View
- Phase I Pipeline View
- Phase II Pipeline View
- Phase III Pipeline View
- Pending Approval Pipeline View
- Approved Pipeline View
- Post Marketing Pipeline View
- on the Market Pipeline View
- Discovery/Development Pipeline View
- Psoriasis Pipeline Overview
About this Product
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
PRINT/CD-ROM:Despatched within 1 to 2 working days.
Related Products
Recently Viewed Products
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















